- DocumentNovexatin Expert Clinical Opinionuploaded byJohn
- DocumentTaro Why the Valuation Discount(1)uploaded byJohn
- DocumentVoice of Shareholders_Surveyuploaded byJohn
- DocumentShareholder Proposals - Annual Shareholders Meetinguploaded byJohn
- DocumentUnconfirmed 645671uploaded byJohn
- DocumentAnacor Investor Presentation June 2013 [Compatibility Mode]uploaded byJohn
- Documentherbalife long thesis dan leobuploaded byJohn
- DocumentTARO VIC thesisuploaded byJohn
- DocumentPerrigo Guidanceuploaded byJohn
- Document12 Civ 8195 Complaintuploaded byJohn
- DocumentDear Members of the TARO Boardv2-0927-Letteruploaded byJohn
- DocumentFusilev (Levoleucovorin) Humana Coverage Policyuploaded byJohn
- Document13282145-marineuploaded byJohn
- DocumentDoc1uploaded byJohn
- DocumentDoc1uploaded byJohn
- Document001 Investor Presentation June2012uploaded byJohn
- Document13272520uploaded byJohn
- DocumentKnightuploaded byJohn
- Document13272520-6uploaded byJohn
- Document13272520-6uploaded byJohn
- Document13272520-3uploaded byJohn
- Document13272520-3uploaded byJohn
- Document13272520-4uploaded byJohn
- DocumentAmrn Response to Final Rejectionuploaded byJohn
- DocumentTarominorityshareholderspetitiontoSpecialCommitteeandBoard-05202012uploaded byJohn
- DocumentAckmanJCPuploaded byJohn
- Documentamended claims-marineuploaded byJohn
- DocumentPatent caseuploaded byJohn
- DocumentMarine patent applicant argumentsuploaded byJohn
- DocumentLavin declarationuploaded byJohn
- DocumentDisclosure Comparisonuploaded byJohn
- DocumentTaro Growthuploaded byJohn
- DocumentTARO Valuation 2uploaded byJohn
- Documentbacuploaded byJohn
- DocumentDisclosure Comparisonuploaded byJohn
- DocumentTARO Valuationuploaded byJohn
- DocumentTaroPharmaceuticalIndustriesLtd_6K_20120405uploaded byJohn
- DocumentTaroPharmaceuticalIndustriesLtd_20F_20120405uploaded byJohn
- Document12815569uploaded byJohn
- DocumentTARO EBIDTA and Sales Growthuploaded byJohn
- DocumentLinked to Win September 14 2011uploaded byJohn
- Document12769885(2)uploaded byJohn
- Document12769885(1)uploaded byJohn
- Document12769885uploaded byJohn
- DocumentTaro pharma 3 years sales and ebidta growthuploaded byJohn
- Document13272520uploaded byJohn
- Document12052598uploaded byJohn
- Document07902500_fj_11_1994uploaded byJohn
- Document07902500-amended_claims_08_1994uploaded byJohn